EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer

Noriaki Sunaga iD, Kyoichi Kaira iD, Kimihiro Shimizu, Ichidai Tanaka, Yosuke Miura, Seshiru Nakazawa, Yoichi Ohtaki iD, Reika Kawabata-Iwakawa, Mitsuo Sato, Luc Girard, John D Minna, Takeshi Hisada

Thoracic Cancer · 2024

DOI: 10.1111/1759-7714.15169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Noriaki Sunaga und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Molecular abnormalities in the Wnt/β‐catenin pathway confer malignant phenotypes in lung cancer. Previously, we identified the association of leucine‐rich repeat‐containing G protein‐coupled receptor 6 (LGR6) with oncogenic Wnt signaling, and its downregulation upon β‐catenin knockdown in non‐small cell lung cancer (NSCLC) cells carrying CTNNB1 mutations. The aim of this study was to explore the mechanisms underlying this association and the accompanying phenotypes.

Methods

LGR6 expression in lung cancer cell lines and surgical specimens was analyzed using quantitative RT‐PCR and immunohistochemistry. Cell growth was assessed using colony formation assay. Additionally, mRNA sequencing was performed to compare the expression profiles of cells subjected to different treatments.

Results

LGR6 was overexpressed in small cell lung cancer (SCLC) and NSCLC cell lines, including the CTNNB1 ‐mutated NSCLC cell lines HCC15 and A427. In both cell lines, LGR6 knockdown inhibited cell growth. LGR6 expression was upregulated in spheroids compared to adherent cultures of A427 cells, suggesting that LGR6 participates in the acquisition of cancer stem cell properties. Immunohistochemical analysis of lung cancer specimens revealed that the LGR6 protein was predominantly overexpressed in SCLCs, large cell neuroendocrine carcinomas, and lung adenocarcinomas, wherein LGR6 overexpression was associated with vascular invasion, the wild‐type EGFR genotype, and an unfavorable prognosis. Integrated mRNA sequencing analysis of HCC15 and A427 cells with or without LGR6 knockdown revealed LGR6‐related pathways and genes associated with cancer development and stemness properties.

Conclusions

Our findings highlight the oncogenic roles of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansWnt Signaling Pathwaybeta CateninRNA, MessengerCell Line, TumorCell ProliferationReceptors, G-Protein-Coupled

Stichwörter der Autor:innen

Wnt pathwaynon-small cell lung canceroncogenesmall cell lung cancerβ-catenin

Substanzen

beta CateninRNA, MessengerLGR6 protein, humanReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
  • Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research, Gunma University, Maebashi, Japan.

ORCID-Profile: Noriaki Sunaga, Kyoichi Kaira, Yoichi Ohtaki

Förderung

  • NCI NIH HHS
  • Japan Society for the Promotion of Science

Zitieren

APA

Sunaga, N., Kaira, K., Shimizu, K., Tanaka, I., Miura, Y., Nakazawa, S., Ohtaki, Y., Kawabata-Iwakawa, R., Sato, M., Girard, L., Minna, J. D., & Hisada, T. (2024). The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15169

Vancouver

Sunaga N, Kaira K, Shimizu K, Tanaka I, Miura Y, Nakazawa S, et al. The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15169

BibTeX
@article{Sunaga2024,
  author = {Sunaga, Noriaki and Kaira, Kyoichi and Shimizu, Kimihiro and Tanaka, Ichidai and Miura, Yosuke and Nakazawa, Seshiru and Ohtaki, Yoichi and Kawabata-Iwakawa, Reika and Sato, Mitsuo and Girard, Luc and Minna, John D and Hisada, Takeshi},
  title = {The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer},
  journal = {Thoracic Cancer},
  year = {2024},
  doi = {10.1111/1759-7714.15169}
}
Kostenlos starten →